Tag: NYSE

SEC receives a response to its invitation for comment on NYSE proposal

by Cydney Posner As discussed in this PubCo post, in early August, the SEC issued an Order instituting proceedings to determine whether to disapprove a proposal from the NYSE to amend Sections 312.03(b) and 312.04 (shareholder approval) of the NYSE Listed Company Manual.  The proposal would exempt from the NYSE’s shareholder approval […]

NYSE proposes amendment related to material news and trading halts

by Cydney Posner The NYSE has filed with the SEC a proposal to amend Section 202.06 of the NYSE Listed Company Manual related to material news and trading halts. The proposal would make the following changes: expand the pre-market hours during which listed companies are required to notify the NYSE […]

How often does this happen?

by Cydney Posner As noted in  yesterday’s thecorporatecounsel.net blog, the SEC has issued an Order instituting  proceedings  under Section 19(b)(2)(B) of the Exchange Act to determine whether to disapprove a proposal to amend Sections 312.03(b) and 312.04 (shareholder approval) of the NYSE Listed Company Manual.  The proposal would exempt from […]

Regulatory salmagundi

by Cydney Posner Release of no-review letters. As you know, the SEC has been releasing the give and take of comment letter correspondence with registrants for a number of years.  Now the SEC has announced that, beginning July 1, 2015, Corp Fin will begin releasing no-review letters on EDGAR with […]

NYSE to biotechs: welcome on board! NYSE loosens initial financial listing standards

by Cydney Posner On September 19, 2014, the NYSE filed with the SEC proposed amendments to Section 102.01C of the NYSE Listed Company Manual to adopt a new initial financial listing  standard for operating companies based on market cap and to eliminate all of the current initial listing financial standards […]